Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
June 30 2020 - 06:38AM
Edgar (US Regulatory)
|
|
SEC
FILE NUMBER |
|
|
|
001-35141 |
|
|
|
|
|
|
|
CUSIP
NUMBER |
|
|
|
759757
800 |
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
one): [ ] Form 10-K [ ] Form 20-F
[ ] Form 11-K [X] Form 10-Q [ ] Form 10-D
[ ] Form N-CEN [ ] Form N-CSR
|
|
For
Period Ended: March 31,
2020 |
|
|
|
|
|
[ ]
Transition Report on Form 10-K |
|
|
|
|
|
[ ]
Transition Report on Form 20-F |
|
|
|
|
|
[ ]
Transition Report on Form 11-K |
|
|
|
|
|
[ ]
Transition Report on Form 10-Q |
|
|
|
|
|
For
the Transition Period Ended:
|
Read
Instruction (on back page) Before Preparing Form. Please Print or
Type.
Nothing
in this form shall be construed to imply that the Commission has
verified any information contained herein.
If
the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Rennova
Health, Inc.
Full
Name of Registrant
Former
Name if Applicable
931 Village Boulevard, Suite 905
Address
of Principal Executive Office (Street and Number)
West
Palm Beach, FL 33409
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort
or expense and the registrant seeks relief pursuant to
Rule 12b-25(b), the following should be completed. (Check box
if appropriate)
|
|
|
|
|
|
|
|
(a) |
|
The
reason described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense; |
|
|
|
|
|
[X] |
|
(b) |
|
The
subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or
portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or subject distribution
report on Form 10-D, or portion thereof, will be filed on or before
the fifth calendar day following the prescribed due date;
and |
|
|
|
|
|
|
|
|
(c) |
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable. |
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D,
N-CEN, N-CSR, or the transition report or portion thereof, could
not be filed within the prescribed time period.
Rennova
Health, Inc. (the “Company”) previously relied on the order (the
“Order”) promulgated by the Securities and Exchange Commission on
March 25, 2020 in Release No. 34-88465 relating to the Securities
Exchange Act of 1934, as amended, to delay the filing of its
Quarterly Report on Form 10-Q for the quarter ended March 31, 2020
(the “Quarterly Report”). On May 15, 2020, the Company filed a
Current Report on Form 8-K (the “Form 8-K”) pursuant to the Order
regarding the exemptive relief due to circumstances related to the
outbreak of the coronavirus (“COVID-19”).
The
COVID-19 pandemic and the steps taken by governments to seek to
reduce the spread of the virus continue to have a severe impact on
the economy and the health care industry in particular. Our
hospitals and the rest of our business continue to experience
disruptions due to the pandemic for the reasons described in our
Form 8-K. The relief provided by the Order allowed for the
Quarterly Report to be filed by June 29, 2020. The Company will not
be able to file the Quarterly Report within that period due to the
additional time required by the Company and its auditors to
complete their respective procedures in light of the circumstances
related to the COVID-19 pandemic, which could not be eliminated
without unreasonable effort or expense.
Persons
who are to respond to the collection of information contained in
this form are not required to respond unless the form displays a
currently valid OMB control number.
(Attach
extra Sheets if Needed)
PART
IV — OTHER INFORMATION
(1) |
|
Name and
telephone number of person to contact in regard to this
notification |
Seamus
Lagan |
|
561 |
|
855-1626 |
(Name) |
|
(Area
Code) |
|
(Telephone
Number) |
|
|
|
|
|
|
|
(2) |
|
Have
all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months
or for such shorter period that the registrant was required to file
such report(s) been filed? If answer is no, identify
report(s). |
|
|
Yes [X] No [ ] |
|
|
|
(3) |
|
Is it
anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof? |
|
|
Yes [ ] No [X] |
|
|
|
|
If
so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be
made. |
Rennova
Health, Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date |
June
29, 2020
|
|
By |
/s/
Seamus Lagan |
|
|
|
|
Seamus
Lagan |
|
|
|
|
Chief
Executive Officer |
Rennova Health (PK) (USOTC:RNVAD)
Historical Stock Chart
From Dec 2020 to Jan 2021
Rennova Health (PK) (USOTC:RNVAD)
Historical Stock Chart
From Jan 2020 to Jan 2021